Roquefort Therapeutics plc
ROQ.L
London Stock Exchange0.95
GBp
-0.05
- -
Total Valuation
Roquefort Therapeutics plc carries a market capitalization of 155,540.00, placing it among publicly traded companies globally.
| Market Cap | 155,540.00 |
| Enterprise Value | N/A |
Stock Price Statistics
Roquefort Therapeutics plc's stock has declined approximately -94.86486% over the past 52 weeks. The 50-day moving average sits at 1.13, while the 200-day moving average is 1.52.
| Beta (5Y) | N/A |
| 52-Week Price Change | -94.86486% |
| 50-Day Moving Average | 1.13 |
| 200-Day Moving Average | 1.52 |
| Average Volume (20 Days) | N/A |
Stock Splits
Roquefort Therapeutics plc's most recent stock split took place on March 27, 2026 with a 10:1 split ratio.
| Last Split Date | 3/27/2026 |
| Split Ratio | 10:1 |